Annual Information Update

RNS Number : 3618Q

Hikma Pharmaceuticals Plc

02 August 2010

 



Annual Information Update

LONDON, 2 August 2010.  In accordance with Prospectus Rule 5.2, Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK) sets out below a summary of the information which has been published or made available to the public over the period. The information referred to in this Update was up to date at the time the information was published, but some information may now be out of date.

Stock Exchange Announcements

Announcements made by the Company via RNS, a Regulatory Information Service, may be viewed and downloaded from the Company's market news section on the London Stock Exchange website at (http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-prices.htm) or from the press releases page on the Company's website at (http://www.hikma.com/investorrelations/rns/). The Stock Exchange announcements made during the period were:

Date of Announcement	Headline of Announcement
14 May 2009	Interim Management Statement
14 May 2009	Result of AGM
19 May 2009	Director/PDMR Shareholding
29 June 2009	Director/PDMR Shareholding
5 August 2009	Total Voting Rights
27 August 2009	Half Yearly Report
1 October 2009	Total Voting Rights
1 October 2009	Additional Listing
16 October 2009	Director/PDMR Shareholding
20 October 2009	Blocklisting Interim Review
2 November 2009	Total Voting Rights
12 November 2009	Interim Management Statement
18 November 2009	Director/PDMR Shareholding
18 November 2009	Director/PDMR Shareholding
19 November 2009	Director/PDMR Shareholding
1 December 2009	Director/PDMR Shareholding
1 December 2009	Total Voting Rights
18 December 2009	Director/PDMR Shareholding
4 January 2010	Total Voting Rights
5 January 2010	Director/PDMR Shareholding
1 February 2010	Total Voting Rights
1 March 2010	Notice of Results
10 March 2010	Total Voting Rights
15 March 2010	Blocklisting of Shares
17 March 2010	Preliminary Announcement for 2009
23 March 2010	Director/PDMR Shareholding
30 March 2010	Hikma expands in the Tunisian market
1 April 2010	Blocklisting Six Monthly return
1 April 2010	Voting Rights & Capital
7 April 2010	Director/PDMR Shareholding
8 April 2010	Director/PDMR Shareholding
9 April 2010	Director/PDMR Shareholding
9 April 2010	Director/PDMR Shareholding
9 April 2010	Annual Financial Report
12 April 2010	Hikma expands in the Algerian market
20 April 2010	Director/PDMR Shareholding
23 April 2010	Director/PDMR Shareholding
5 May 2010	Voting Rights & Capital
13 May 2010	Interim Management Statement
13 May 2010	AGM Statement
26 July 2010	Voting Rights and Capital

All of the above announcements were also made by the Company via the NasdaqDubai stock exchange CANDI system.  These announcements may be viewed and downloaded from the NasdaqDubai website (www.candi.nasdaq.com). 

Documents filed with the Financial Services Authority

The Company has filed the following documents with the Financial Services Authority ("FSA") over the previous 12 months.  These documents are available to be viewed via the UKLA's Document Viewing Facility at the Financial Services Authority, 25 the North Colonnade, London, E14 5HS or at the Company's registered office.

Date	Document
9 April 2010	Annual Report and Accounts 2009
9 April 2010	Notice of 2010 Annual General Meeting
9 April 2010	Proxy forms for the 2010 Annual General Meeting
9 April 2010	Sterling and Jordanian Dinar dividend election forms

Documents filed with Companies House

The Company submitted filings to the Registrar of Companies in England and Wales as detailed in the table below. 

Date Filed	Form	Description
30 July 2010	SH01	31/05/10 statement of capital GBP 19326339
30 July 2010	SH01	30/04/10 statement of capital GBP 19313279
23 July 2010	SH01	31/03/10 statement of capital GBP 19260000
9 June 2010	AA	Group of companies' accounts made up to 31/12/09
8 June 2010	RES01	Alteration to memorandum and articles
8 June 2010	RES10	Authorised allotment of shares and debentures
8 June 2010	RES09	Authority to purchase shares other than from capital
8 June 2010	RES11	Disapplication of pre-emption rights
26 May 2010	RES10	Authorised allotment of shares and debentures
26 May 2010	RES01	Alteration to memorandum and articles
26 May 2010	RES11	Disapplication of pre-emption rights
19 April 2010	SH01	31/01/10 statement of capital GBP 19176400
19 April 2010	SH01	30/11/09 statement of capital GBP 19156490
19 April 2010	SH01	31/12/09 statement of capital GBP 19162760
16 April 2010	SH01	31/03/10 statement of capital GBP 19260000
15 October 2009	AD03	Register(s) moved to sail address
15 October 2009	AD02	Sail address created
29 September 2009	363a	Return made up to 08/09/09; bulk list available separately
24 September 2009	88(2)	AD 01/07/09-30/07/09 issued share capital  GBP IC 18982880/18983480
24 September 2009	88(2)	AD 01/06/09-30/06/09 issued share capital  GBP IC 18959440/18982880
24 September 2009	88(2)	AD 01/05/09-30/05/09 issued share capital  GBP IC 18940080/18959440
24 September 2009	88(2)	AD 01/04/09-30/04/09 issued share capital  GBP IC 18912440/18940080
24 September 2009	88(2)	AD 01/03/09 to 30/03/09 issued share capital  GBP IC 18888160/18912440
25 July 2009	AA	Group of companies' accounts made up to 31/12/08
3 June 2009	RES10	Authorised allotment of shares and debentures
3 June 2009	RES13	Approve remuneration committee report 14/05/2009
3 June 2009	RES09	Authority to purchase shares other than from capital
3 June 2009	RES11	Disapplication of pre-emption rights

Copies of all these documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a registered user, they may be viewed and downloaded using Companies House Direct at www.direct.companieshouse.gov.uk.

Further Information

Further information about Hikma Pharmaceuticals PLC can be found at our website www.hikma.com. Copies of all documents can be obtained from the Company at the registered office which is located at 13 Hanover Square, London W1S 1HW.

Henry Knowles
Company Secretary
2 August 2010

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC
Henry Knowles Company Secretary	[phone]
Susan Ringdal Investor Relations Director	[phone]
Financial Dynamics
Ben Atwell/ Julia Phillips		[phone]
Jonathan Birt/ Matthew Cole

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed  products.  Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe.  In 2009, Hikma achieved revenues of $637 million and profit attributable to shareholders of $78 million.  For news and other information, please visit www.hikma.com.

 

END

 

 

AIUFLLFBBVFFBBE